|
Variables
|
n = 97
|
|---|
|
Age (years)
|
54.0 ± 11.3
|
|
Female, n (%)
|
82 (84.5)
|
|
Autoantibodies positive, n (%)
|
83 (85.6)
|
|
ANA + , n (%)
|
78 (80.4)
|
|
ASMA + , n (%)
|
24 (24.7)
|
|
Anti-LKM1 + , n (%)
|
3 (3.1)
|
|
Anti-LC1, n (%)
|
2 (2.1)
|
|
Anti-SLA/LP, n (%)
|
2 (2.1)
|
|
IgG (g/L)
|
16.80 (13.35, 21.10)
|
|
ALT (U/L)
|
88.0 (32.0, 322.5)
|
|
AST (U/L)
|
113.0 (35.0, 401.0)
|
|
ALP (U/L)
|
110.0 (75.5, 151.0)
|
|
GGT (U/L)
|
125.9 (59.0, 248.0)
|
|
TBIL (μmol/L)
|
20.0 (12.7, 68.4)
|
|
ALB (g/L)
|
40.1 ± 5.6
|
|
PLT (× 109/L)
|
184.8 ± 70.5
|
|
PT (s)
|
13.2 ± 1.5
|
|
Iron (μmol/L)
|
27.7 ± 14.4
|
|
Transferrin (g/L)
|
2.67 (2.28, 3.17)
|
|
Ferritin (μg/L)
|
214.0 (78.0, 515.0)
|
|
UIBC (μmol/L)
|
31.2 (21.2, 48.2)
|
|
TIBC (μmol/L)
|
59.8 (53.8, 68.9)
|
|
TSI (%)
|
43.6 (28.2, 64.2)
|
|
AIH score (1999)
|
15.8 ± 2.7
|
|
AIH score (2008)
|
7.5 ± 1.3
|
|
Histology (inflammation), n (%)
|
|
G0
|
0 (0)
|
|
G1
|
3 (3.1)
|
|
G2
|
42 (43.3)
|
|
G3
|
40 (41.2)
|
|
G4
|
12 (12.4)
|
|
Histology (fibrosis), n (%)
|
|
F0
|
11 (11.3)
|
|
F1
|
22 (22.7)
|
|
F2
|
26 (26.8)
|
|
F3
|
21 (21.6)
|
|
F4
|
17 (17.5)
|
- Data are expressed as mean (± standard deviation), median (quartile 25, quartile 75) or number (proportion)
- ANA antinuclear antibody, ASMA anti-smooth muscle antibody, Anti-LKM1 anti-liver kidney microsomal antibody type 1, Anti-LC1 anti-liver cytosol type 1 antibody, Anti-SLA/LP anti-soluble liver antigen or anti-liver-pancreas antibodies, IgG immunoglobulin G, ALT alanine aminotransferase, AST aspartate aminotransferase, ALP alkaline phosphatase, GGT gamma-glutamyl transpeptidase, TBIL total bilirubin, ALB albumin, PLT platelet, PT prothrombin time, UIBC unsaturated iron binding capacity, TIBC Total iron binding capacity, TSI transferrin saturation index
